537 related articles for article (PubMed ID: 11087909)
41. Deregulation of sphingolipid metabolism in Alzheimer's disease.
He X; Huang Y; Li B; Gong CX; Schuchman EH
Neurobiol Aging; 2010 Mar; 31(3):398-408. PubMed ID: 18547682
[TBL] [Abstract][Full Text] [Related]
42. [Activity of the sphingomyelin cycle enzymes and concentration of products of sphingomyelin degradation in the rat liver in the course of acute toxic hepatitis].
Serebrov VIu; Kuz'menko DI; Burov PG; Sapugol'tseva OB
Biomed Khim; 2010; 56(2):283-9. PubMed ID: 21341516
[TBL] [Abstract][Full Text] [Related]
43. Characterization of secretory sphingomyelinase activity, lipoprotein sphingolipid content and LDL aggregation in ldlr-/- mice fed on a high-fat diet.
Deevska GM; Sunkara M; Morris AJ; Nikolova-Karakashian MN
Biosci Rep; 2012 Oct; 32(5):479-90. PubMed ID: 22712892
[TBL] [Abstract][Full Text] [Related]
44. Hyperthyroidism evokes myocardial ceramide accumulation.
Mikłosz A; Łukaszuk B; Chabowski A; Rogowski F; Kurek K; Żendzian-Piotrowska M
Cell Physiol Biochem; 2015; 35(2):755-66. PubMed ID: 25613909
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of the role of secretory sphingomyelinase and bioactive sphingolipids as biomarkers in hemophagocytic lymphohistiocytosis.
Jenkins RW; Clarke CJ; Lucas JT; Shabbir M; Wu BX; Simbari F; Mueller J; Hannun YA; Lazarchick J; Shirai K
Am J Hematol; 2013 Nov; 88(11):E265-72. PubMed ID: 23828274
[TBL] [Abstract][Full Text] [Related]
46. Mechanisms of sphingosine and sphingosine 1-phosphate generation in human platelets.
Tani M; Sano T; Ito M; Igarashi Y
J Lipid Res; 2005 Nov; 46(11):2458-67. PubMed ID: 16061940
[TBL] [Abstract][Full Text] [Related]
47. CDase is a pan-ceramidase in Drosophila.
Yuan C; Rao RP; Jesmin N; Bamba T; Nagashima K; Pascual A; Preat T; Fukusaki E; Acharya U; Acharya JK
Mol Biol Cell; 2011 Jan; 22(1):33-43. PubMed ID: 21148295
[TBL] [Abstract][Full Text] [Related]
48. Sphingomyelinases and Liver Diseases.
Insausti-Urkia N; Solsona-Vilarrasa E; Garcia-Ruiz C; Fernandez-Checa JC
Biomolecules; 2020 Oct; 10(11):. PubMed ID: 33143193
[TBL] [Abstract][Full Text] [Related]
49. Increases in ceramide levels in normal human mesangial cells subjected to different cellular stresses result from changes in distinct enzyme activities and can influence cellular responses to other stimuli.
Sweeney EA; Igarashi Y
J Biochem; 1999 Apr; 125(4):737-45. PubMed ID: 10101287
[TBL] [Abstract][Full Text] [Related]
50. Increase of nuclear ceramide through caspase-3-dependent regulation of the "sphingomyelin cycle" in Fas-induced apoptosis.
Watanabe M; Kitano T; Kondo T; Yabu T; Taguchi Y; Tashima M; Umehara H; Domae N; Uchiyama T; Okazaki T
Cancer Res; 2004 Feb; 64(3):1000-7. PubMed ID: 14871831
[TBL] [Abstract][Full Text] [Related]
51. Simultaneous quantitative analysis of ceramide and sphingosine in mouse blood by naphthalene-2,3-dicarboxyaldehyde derivatization after hydrolysis with ceramidase.
He X; Dagan A; Gatt S; Schuchman EH
Anal Biochem; 2005 May; 340(1):113-22. PubMed ID: 15802137
[TBL] [Abstract][Full Text] [Related]
52. Activation of ceramidase and ceramide kinase by vanadate via a tyrosine kinase-mediated pathway.
Tada E; Toyomura K; Nakamura H; Sasaki H; Saito T; Kaneko M; Okuma Y; Murayama T
J Pharmacol Sci; 2010; 114(4):420-32. PubMed ID: 21127389
[TBL] [Abstract][Full Text] [Related]
53. Ceramide- and ERK-dependent pathway for the activation of CCAAT/enhancer binding protein by interleukin-1beta in hepatocytes.
Giltiay NV; Karakashian AA; Alimov AP; Ligthle S; Nikolova-Karakashian MN
J Lipid Res; 2005 Nov; 46(11):2497-505. PubMed ID: 16106045
[TBL] [Abstract][Full Text] [Related]
54. Identification of a Novel Acid Sphingomyelinase Activity Associated with Recombinant Human Acid Ceramidase.
He X; Schuchman EH
Biomolecules; 2023 Nov; 13(11):. PubMed ID: 38002305
[TBL] [Abstract][Full Text] [Related]
55. Sphingolipids in psychiatric disorders and pain syndromes.
Mühle C; Reichel M; Gulbins E; Kornhuber J
Handb Exp Pharmacol; 2013; (216):431-56. PubMed ID: 23563670
[TBL] [Abstract][Full Text] [Related]
56. Ceramide metabolism is affected by obesity and diabetes in human adipose tissue.
Błachnio-Zabielska AU; Pułka M; Baranowski M; Nikołajuk A; Zabielski P; Górska M; Górski J
J Cell Physiol; 2012 Feb; 227(2):550-7. PubMed ID: 21437908
[TBL] [Abstract][Full Text] [Related]
57. Effects of flavonoids on sphingolipid turnover in the toxin-damaged liver and liver cells.
Babenko NA; Shakhova EG
Lipids Health Dis; 2008 Jan; 7():1. PubMed ID: 18226198
[TBL] [Abstract][Full Text] [Related]
58. Regulation of the activity and fatty acid specificity of lecithin-cholesterol acyltransferase by sphingomyelin and its metabolites, ceramide and ceramide phosphate.
Subbaiah PV; Horvath P; Achar SB
Biochemistry; 2006 Apr; 45(15):5029-38. PubMed ID: 16605271
[TBL] [Abstract][Full Text] [Related]
59. Resveratrol Affects Sphingolipid Metabolism in A549 Lung Adenocarcinoma Cells.
Momchilova A; Pankov R; Staneva G; Pankov S; Krastev P; Vassileva E; Hazarosova R; Krastev N; Robev B; Nikolova B; Pinkas A
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142801
[TBL] [Abstract][Full Text] [Related]
60. Sphingomyelinase and cell-permeable ceramide analogs stimulate cellular proliferation in quiescent Swiss 3T3 fibroblasts.
Olivera A; Buckley NE; Spiegel S
J Biol Chem; 1992 Dec; 267(36):26121-7. PubMed ID: 1464623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
